LRCX vs VECO: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
LRCX is the larger of the two ($229.44B market cap): the incumbent the market prices for continued execution (14.97x forward earnings, beta 2.01). VECO is the smaller challenger ($2.08B), cheaper on forward earnings (11.86x): more room to run, but more to prove. On the numbers, VECO leads on both counts: faster expected revenue growth (33% vs 21%) and a lower forward P/E (11.86x vs 14.97x). The case for LRCX rests on its own driver (AI-driven chip-capex supercycle): if you believe in that, LRCX fits; if you believe in what the numbers show today, VECO does.
LRCX vs VECO: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | LRCX | VECO | What it tells you |
|---|---|---|---|
| Market cap | $229.44B | $2.08B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 14.97 | 11.86 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 27.37 | 83.10 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 2.01 | 1.42 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 16% of range | 13% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 16.50 | 2.25 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: VECO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how LRCX and VECO affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. LRCX and VECO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined LRCX and VECO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Lam Research (LRCX) do?
Lam Research is one of the largest semiconductor equipment makers in the world, specializing in wafer-fabrication tools used to build integrated circuits. It is a leader in two critical process steps: etch (precisely removing material to carve nanoscale features) and deposition (laying down ultra-thin films of material), along with related cleaning and surface-preparation systems. These steps are repeated hundreds of times to build modern 3D chip structures, and Lam's tools are essential to manufacturing advanced logic and especially memory chips (DRAM and NAND flash). Lam sells its systems to the world's leading chipmakers and foundries, then earns a large, recurring stream of revenue from spare parts, upgrades, and services for its big installed base of tools, which smooths the cyclical equipment-sales business. Demand is driven by capital spending from semiconductor manufacturers, which rises and falls with chip-industry cycles but trends structurally higher as AI, data centers, and advanced devices require more and more sophisticated chips. Headquartered in Fremont, California, Lam is a key enabler of leading-edge and memory chip production.
What does Veeco Instruments (VECO) do?
Veeco Instruments is a US-based maker of semiconductor process equipment. Its systems handle specific, enabling steps in chip and device fabrication rather than the whole line: laser annealing for leading-edge logic and foundry chips, ion beam deposition and etch, metal organic chemical vapor deposition (MOCVD) for compound semiconductors, single-wafer wet processing and etch for advanced packaging, and lithography and inspection tools. Its customers include leading logic and memory foundries, compound-semiconductor and photonics makers, and data-storage manufacturers. Veeco competes by focusing on specialized niches instead of going head-to-head across the full toolset with the largest equipment vendors.
LRCX vs VECO: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- LRCX drivers: AI-driven chip-capex supercycle; Leadership in etch and deposition.
- VECO drivers: AI optics and indium phosphide lasers; Leading-edge logic and advanced packaging.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Semiconductor equipment is highly cyclical, and Lam's new-tool sales swing sharply with chipmaker capital-spending cycles, especially in memory, which is among the most volatile end markets. For VECO, veeco's results are cyclical and depend on semiconductor and data-storage capital spending, which the company does not control and which swings with chip demand, inventory cycles, and customer capex plans.
LRCX or VECO: which should you pick?
If the story you believe is LRCX's (AI-driven chip-capex supercycle), LRCX is the more direct way to own it; if it is VECO's (AI optics and indium phosphide lasers), VECO is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the LRCX and VECO guides.
LRCX vs VECO: the full fundamentals
LRCX. At about $184 on November 20, 2026, Lam trades near 27 times trailing earnings and about 15 times analysts' fiscal 2028 EPS estimate of ~$12.27, a sharp compression from roughly 47x trailing in October even though earnings kept rising. The 30 analysts covering it have a mean target of about $362, nearly double the price, which shows how far the market's read on AI-driven memory and logic capex has moved away from the published estimates (fiscal 2027 revenue near $35.4 billion). The next report, estimated for late January 2027, carries consensus EPS of about $2.35 on ~$8.64 billion of revenue.
VECO. Revenue is growing again (Q3 2026 up ~26% year over year to ~$209 million), but GAAP profits remain thin, so the trailing P/E near 83x looks extreme while the forward P/E on 2027 estimates of ~$2.87 is about 12x. That forward multiple leans on analysts' expectation of roughly $1.04 billion of 2027 revenue, in line with management's target of more than $1 billion. Q4 2026 consensus is about $0.61 of EPS on ~$245 million of revenue; figures are approximate as of November 20, 2026.
Headline figures (approximate, November 2026): LRCX shows revenue (ttm) ~$26.1 billion (September 2026 quarter ~$8.22B, +54% y/y), margins Gross ~51%, operating ~37%, net ~32% (Q1 FY2027 non-GAAP gross 52.4%), net income (ttm) ~$8.45 billion (EPS ~$6.71), p/e (trailing / forward) ~27x / ~15x; VECO shows revenue (ttm) ~$726 million (Q3 up ~26% YoY), net income (ttm, gaap) ~$26 million, gross / operating margin ~38% / ~5%, p/e (trailing / forward) ~83x / ~12x.
The bottom line: LRCX vs VECO
LRCX and VECO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined LRCX and VECO exposure against your real portfolio. It is not an investment adviser.
Wondering how LRCX or VECO fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Lam Research
Ask Walnut's AI anything about LRCX and see how it fits what you own.
FAQ
What is the difference between LRCX and VECO?
+
Lam Research is one of the largest semiconductor equipment makers in the world, specializing in wafer-fabrication tools used to build integrated circuits. Veeco Instruments is a US-based maker of semiconductor process equipment. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is LRCX or VECO the better stock?
+
Neither is universally better. LRCX is the larger incumbent; VECO is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, LRCX or VECO?
+
On forward P/E (as of November 2026), LRCX trades at 14.97x and VECO at 11.86x, so VECO is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both LRCX and VECO?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of LRCX vs VECO?
+
LRCX: Semiconductor equipment is highly cyclical, and Lam's new-tool sales swing sharply with chipmaker capital-spending cycles, especially in memory, which is among the most volatile end markets. US export restrictions on advanced chipmaking equipment to China are a significant headwind, since China has been a large customer; tighter rules can cut a meaningful slice of revenue. Customer concentration among a handful of large chipmakers, intense competition from Applied Materials and Tokyo Electron, and sensitivity to memory pricing and macro demand all add risk. A downturn in chip capex or escalating trade restrictions would pressure results and the stock. China rose to 35% of revenue in the September 2026 quarter, so any tightening lands on a larger base, and management already expects that share to fall significantly in the December quarter. Valuation has been the other risk: at about 47 times trailing earnings in October the shares priced in a strong fiscal 2027, and the ~42% drop over the three months to November 20, 2026, during a quarter of record revenue, shows how quickly sentiment on AI capex can turn. VECO: Veeco's results are cyclical and depend on semiconductor and data-storage capital spending, which the company does not control and which swings with chip demand, inventory cycles, and customer capex plans. Revenue is concentrated among a limited number of large customers and can be lumpy quarter to quarter, so a delayed or canceled order can move results. The stock re-rated substantially on AI-optics optimism and has shown how quickly that can reverse: it fell from a 52-week high near $87 to ~$34 by November 20, 2026, including ~19% in the month after the Q3 miss, and it still trades around 83x trailing GAAP earnings, a multiple that could compress further if growth disappoints or the indium phosphide ramp slows. Q3 gross margin of about 39% was below expectations on higher supply-chain costs and mix, and rising input costs may not be passed through on existing backlog. Export controls are a live issue: revenue on one laser annealing system was delayed by a US government export review, and China revenue (about 12% of Q3 sales) is expected to keep shrinking. The pending Axcelis merger adds deal-related uncertainty (China regulatory review, timing, integration, and exposure to the Axcelis share price for an all-stock deal). Veeco also faces intense competition from far larger equipment makers and the risk that a specific niche (such as compound semis or data storage) turns down faster than expected.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell LRCX or VECO; figures are approximate and dated (as of November 2026). Verify current data before investing.